Ypsomed announced today that it selected Samuel Künzli to take over the company’s chief financial officer (CFO) position.
Niklaus Ramseier elected to hand over the reins to the CFO position after more than 20 years in the post. The transition begins on March 31, 2024, with Ramseier remaining available to the drug delivery device maker for strategic projects. Künzli begins as CFO on April 1, 2024.
Get the full story at our sister site, Drug Delivery Business News.